L 122/30 Official Journal of the European Communities 12.5.1999 COMMISSION REGULATION (EC) No 998/1999 of 11 May 1999 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance) THE COMMISSION OF THE EUROPEAN COMMUNITIES, maximum residue limits should therefore also always be established for muscle or fat tissues; Having regard to the Treaty establishing the European (5)  Whereas, in the case of veterinary medicinal prod- Community, ucts intended for use in laying birds, lactating animals or honey bees, maximum residue limits must also be established for eggs, milk or honey; Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for (6)  Whereas danofloxacin should be inserted into the establishment of maximum residue limits of veter- Annex I to Regulation (EEC) No 2377/90; inary medicinal products in foodstuffs of animal origin (*), as last amended by Commission Regulation (EC) No 997/ (7)  Whereas tiaprost, convallaria majalis, atropa 1999 (%), and in particular Articles 6 and 8 thereof, belladonna, aqua levici and adonis wvernalis should be inserted into Annex II to Regulation (EEC) No 2377/90; (1)  Whereas, in accordance with Regulation (EEC) No 2377/90, maximum residue limits must be estab- 8)  Whereas a period of 60 days should be allowed lished progressively for all pharmacologically active before the entry into force of this Regulation in substances which are used within the Community order to allow Member States to make any adjust- in veterinary medicinal products intended for ment which may be necessary to the authorisations administration to food-producing animals; to place the veterinary medicinal products concerned on the market which have been granted in accordance with Council Directive 81/ (2) Whereas maximum residue limits should be estab- 851/EEC (%), as last amended by Directive 93/ lished only after the examination within the 40/EEC (%), to take account of the provisions of this Committee for Veterinary Medicinal Products of all Regulation; the relevant information concerning the safety of residues of the substance concerned for the (9)  Whereas the measures provided for in this Regula- consumer of foodstuffs of animal origin and the tion are in accordance with the opinion of the impact of residues on the industrial processing of Standing Committee on Veterinary Medicinal foodstuffs; Products, (3)  Whereas, in establishing maximum residue limits for residues of veterinary medicinal products in foodstuffs of animal origin, it is necessary to specify HAS ADOPTED THIS REGULATION: the animal species in which residues may be present, the levels which may be present in each of the relevant meat tissues obtained from the treated Article 1 animal (target tissue) and the nature of the residue which is relevant for the monitoring of residues DN Annexes I and II to Regulation (EEC) No 2377/90 are (marker residue); hereby amended as set out in the Annex hereto. (40  Whereas, for the control of residues, as provided for in appropriate Community legislation, maximum Article 2 residue limits should usually be established for the target tissues of liver or kidney; whereas, however, This Regulation shall enter into force on the 60th day the liver and kidney are frequently removed from following its publication in the Official Journal of the carcarses moving in international trade, and European Communities. () OJ L 224, 18.8.1990, p. 1 ' () OJ L 317, 6.11.1981, p. 1. (%) See page 24 of this Official Journal. ¢ O] L 4 214, 24.8.1993, p. 31.